The Stanford Medicine physician and other renowned experts will deliver critical insights and perspectives on the management of lung cancer.
Physicians’ Education Resource®, LLC (PER®), is pleased to announce that Heather A. Wakelee, M.D., professor of oncology at Stanford Medicine in California, will join the prestigious panel of program co-chairs at the 21st Annual International Lung Cancer Congress®. The conference will take place July 23-25 as a live, interactive CME-certified virtual webcast.
The other co-chairs leading the 2020 congress are:
- David R. Gandara, M.D., professor of medicine, division of hematology/oncology, UC Davis School of Medicine, Sacramento, California; director of the thoracic oncology program and senior adviser to director, UC Davis Comprehensive Cancer Center.
- Roy S. Herbst, M.D., Ph.D., ensign professor of medical oncology, professor of pharmacology; chief of medical oncology, Yale Cancer Center’s Smilow Cancer Hospital in New Haven, Connecticut; associate cancer director for translational research, Yale Cancer Center.
"We are eager to have Dr. Wakelee join the leadership team for our upcoming comprehensive expert-developed lung cancer program this July," said Phil Talamo, president of PER®. "As the leading go-to resource for continuing medical education, we are proud to work with such renowned in the field and look forward to the powerhouse panel of co-chairs to discuss the most relevant and impactful strategies in the treatment and management of lung cancers."
For 21 years, the International Lung Cancer Congress® has brought together medical, surgical and radiation oncologists to foster awareness of state-of-the-art treatments for patients with lung cancer. During this two-day webcast, leading international and national experts will provide perspectives on how to apply the latest data on targeted agents, immunotherapy, surgery and radiation oncology in the clinic. Cutting-edge lectures, panel discussions, multidisciplinary tumor boards and interactive question-and-answer sessions will provide a unique opportunity for participants to engage with the faculty as they share their perspectives and personal experiences on the clinical challenges and ongoing controversies in lung cancer management.
Dr. Wakelee added, "The ILCC has played a central role in my career development since my first conference participation in 2002 when I was an oncology fellow. I have never missed a meeting and am delighted to now step into a leadership role along with Drs. Gandara and Herbst."
Accredited by the Accreditation Council for Continuing Medical Education and approved by the California Board of Registered Nursing, this live webcast will provide participants with the opportunity to earn up to 20.5 AMA PRA Category 1 Credits™ and 20.5 nursing contact hours.
For more information and to register, click here.
About Physicians’ Education Resource®, LLC (PER®)
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now advances patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While expanding into topics outside of oncology, PER® stands as the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.
PER® Media Contact
Alexandra Ventura, 609-716-7777, ext. 121